Conference
The Neurokinin-1 Receptor Antagonist Orvepitant is a Novel Anti-Tussive Therapy for Chronic Refractory Cough: Results from a Phase 2 Study (VOLCANO-1)
Authors
Smith JA; Allman D; Badri H; Miller R; Morris J; Satia I; Wood A; Trower M
Volume
195
Pagination
pp. a2672-a2672
Publication Date
January 1, 2017
DOI
10.1164/ajrccm-conference.2017.195.1_meetingabstracts.a2672
Conference proceedings
American Journal of Respiratory and Critical Care Medicine
Issue
Supplement_1
ISSN
1073-449X
